CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Advances in the treatment of malignant ascites in China.
Advances in the treatment of malignant ascites in China.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
尽管 MA 的治疗已取得显著进展,但仍属临床难点之一。探索疗效最佳且不良反应最少的药物联合方案或治疗方法以控制 MA,仍是亟待解决的问题。
恶性腹水(MA)常发生于复发性腹部恶性肿瘤,癌性腹膜炎相关的大量腹水不仅导致严重腹胀和呼吸困难,还降低患者的生活质量和抗病能力,通常使抗癌治疗难以进行。MA治疗方法的探索也是MA治疗中的关键环节。本文拟对MA的治疗进行综述,为进一步研究MA的治疗提供细节,并为MA的临床治疗提供一定指导。
本综述分析了多篇专家论文并对其进行总结以形成本文。
MA的治疗方法多种多样,包括全身治疗和局部治疗。其中,全身治疗包括利尿剂治疗、化疗、免疫治疗、靶向治疗、抗血管生成治疗、CAR-T 和疫苗。局部治疗包括穿刺手术、腹腔静脉分流手术、无细胞腹水输注治疗、放射性核素腹腔注射治疗、隧道导管和腹腔热灌注化疗。而中医治疗在一定程度上也起到了增效减毒的作用。
Malignant ascites (MA) often occurs in recurrent abdominal malignant tumors, and the large amount of ascites associated with cancerous peritonitis not only leads to severe abdominal distension and breathing difficulties, but also reduces the patient's quality of life and ability to resist diseases, which usually makes it difficult to carry out anti-cancer treatment. The exploration of MA treatment methods is also a key link in MA treatment. This article is going to review the treatment of MA, to provide details for further research on the treatment of MA, and to provide some guidance for the clinical treatment of MA. METHOD: This review analyzes various expert papers and summarizes them to obtain the paper. RESULT: There are various treatment methods for MA, including systemic therapy and local therapy. Among them, systemic therapy includes diuretic therapy, chemotherapy, immunotherapy, targeted therapy, anti angiogenic therapy, CAR-T, and vaccine. Local therapy includes puncture surgery, peritoneal vein shunt surgery, acellular ascites infusion therapy, radioactive nuclide intraperitoneal injection therapy, tunnel catheter, and intraperitoneal hyperthermia chemotherapy. And traditional Chinese medicine treatment has also played a role in enhancing efficacy and reducing toxicity to a certain extent.
Although there has been significant progress in the treatment of MA, it is still one of the clinical difficulties. Exploring the combination or method of drugs with the best therapeutic effect and the least adverse reactions to control MA is still an urgent problem to be solved.
MEMBER ACCOUNT
登录成功会直接打开下一页。